Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.4215 | 16 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.39877 | 16 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.40545 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.3658 | 17 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.30443 | 14 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.41918 | 15 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.4518 | 17 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.59131 | 26 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.36111 | 16 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.39923 | 17 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.41191 | 17 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.36982 | 16 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.39131 | 16 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.39665 | 16 |